scispace - formally typeset
Open AccessJournal ArticleDOI

Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition

Marcel Arnold
Reads0
Chats0
TLDR
The 3rd edition of the International Classification of Headache Disorders (ICHD-3) may be reproduced freely for scientific, educational or clinical uses by institutions, societies or individuals if the Society’s permission is granted.
Abstract
The 3rd edition of the International Classification of Headache Disorders (ICHD-3) may be reproduced freely for scientific, educational or clinical uses by institutions, societies or individuals. Otherwise, copyright belongs exclusively to the International Headache Society. Reproduction of any part or parts in any manner for commercial uses requires the Society’s permission, which will be granted on payment of a fee. Please contact the publisher at the address below. International Headache Society 2013–2018. Applications for copyright permissions should be submitted to Sage Publications Ltd, 1 Oliver’s Yard, 55 City Road, London EC1Y 1SP, United Kingdom (tel: þ44 (0) 207 324 8500; fax: þ44 (0) 207 324 8600; permissions@sagepub.co.uk) (www.uk.sagepub.com). Translations

read more

Citations
More filters
Journal ArticleDOI

Pathophysiology of Migraine: A Disorder of Sensory Processing

TL;DR: Investment in understanding migraine leaves us at a new dawn, able to transform its impact on a global scale, as well as understand fundamental aspects of human biology.
Journal ArticleDOI

Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016

TL;DR: New estimates for prevalence and years of life lived with disability (YLDs) for migraine and tension-type headache using data from the GBD 2016 study show that headache disorders, and migraine in particular, are important causes of disability worldwide, and deserve greater attention in health policy debates and research resource allocation.
Journal ArticleDOI

A Controlled Trial of Erenumab for Episodic Migraine.

TL;DR: Erenumab administered subcutaneously at a monthly dose of 70 mg or 140 mg significantly reduced migraine frequency, the effects of migraines on daily activities, and the use of acute migraine–specific medication over a period of 6 months.
Journal ArticleDOI

Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine

Padhraig Gormley, +133 more
- 01 Aug 2016 - 
TL;DR: For example, the authors identified 44 independent single-nucleotide polymorphisms (SNPs) significantly associated with migraine risk (P < 5 × 10−8) that mapped to 38 distinct genomic loci, including 28 loci not previously reported and a locus that to date is the first to be identified on chromosome X.
References
More filters
Journal ArticleDOI

Epidemiology of headache in a general population—A prevalence study

TL;DR: The prevalence of tension-type headache decreased with increasing age, whereas migraine showed no correlation to age within the studied age interval.
Journal ArticleDOI

Epidemiology and comorbidity of headache

TL;DR: Renewed recognition of the burden of headache and increased scientific interest have led to a better understanding of the risk factors and greater insight into the pathogenic mechanisms, which might lead to improved prevention strategies and the early identification of patients who are at risk.
Journal ArticleDOI

Central sensitization in tension-type headache—possible pathophysiological mechanisms

TL;DR: It was concluded that the central pain sensitivity was increased in the patients probably due to sensitization of supraspinal neurones, and the qualitatively altered nociception was likely due to central sensitization at the level of the spinal dorsal horn/trigeminal nucleus.
Journal ArticleDOI

Myofascial trigger points show spontaneous needle EMG activity.

TL;DR: The authors hypothesize that TrPs are caused by sympathetically activated intrafusal contractions.
Journal ArticleDOI

Management of chronic tension-type headache with tricyclic antidepressant medication, stress management therapy, and their combination: a randomized controlled trial.

TL;DR: The results indicate that antidepressant medication and stress management therapy are each modestly effective in treating chronic tension-type headaches.
Related Papers (5)

The International Classification of Headache Disorders, 3rd edition (beta version)

Jes Olesen, +131 more
- 01 Jul 2013 - 

Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

Theo Vos, +778 more
- 16 Sep 2017 -